4//SEC Filing
Cerulean Pharma Inc. 4
Accession 0001209191-17-002970
$DARECIK 0001401914operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:08 PM ET
Size
5.6 KB
Accession
0001209191-17-002970
Insider Transaction Report
Form 4
BELOFF GREGG
Interim CFO
Transactions
- Award
Stock Option (right to buy)
2017-01-05+50,000→ 50,000 totalExercise: $0.82Exp: 2027-01-04→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 5, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019.
Documents
Issuer
Cerulean Pharma Inc.
CIK 0001401914
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401914
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:08 PM ET
- Size
- 5.6 KB